Viral Hepatitis C - VGX Pharmaceuticals Announces Filing of IND Application for the

VGX Pharmaceuticals Announces Filing of IND Application for the
VGX Pharmaceuticals Announces Filing of IND Application for the treatment of Hepatitis C infection Blue Bell, PA -- July 21, 2005 -- VGX Pharmaceuticals announced that the company has

News
Impact of Chronic Hepatitis C Infection on Outcomes of Patients with an Advanced Stage of HIV-1 Infection in an Area of Low Prevalence of Co-infection Fibrosis Heterogeneity in Nonalcoholic

AADMC: Selected Articles 2000: Review of hepatitis C infection
Review of hepatitis C infection Summary There is concern about the increasing prevalence of hepatitis C (Hep C) infection and its contribution to chronic liver diseases. As

Pegasys Studied in Post-Liver Transplant Patients with Recurrent
RECURRENT HEPATITIS C INFECTION -- Investigational Treatment Options for Most Difficult to Treat Patients -- Preliminary data presented in a plenary session at the American Society of Liver